Bahat, G.; Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, Istanbul, 34093, Turkey
Catikkas, N. M.; Division of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, Istanbul, 34093, Turkey
Yavuz, D. G.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Marmara Medical School, Marmara University, Istanbul, Turkey
Borman, P.; Department of Physical Medicine and Rehabilitation, Hacettepe Medical School, Hacettepe University, Ankara, Turkey
Guzel, R.; Department of Physical Medicine and Rehabilitation, Cukurova Medical School, Cukurova University, Adana, Turkey
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations
Publication date :
2021
Journal title :
Archives of Osteoporosis
ISSN :
1862-3522
eISSN :
1862-3514
Publisher :
Springer Science and Business Media Deutschland GmbH
IOF. Access date September 22, 2021. https://www.osteoporosis.foundation/health-professionals/fragilityfractures/epidemiology
Ensrud KE (2013) Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci 68(10):1236–1242. 10.1093/gerona/glt092 DOI: 10.1093/gerona/glt092
Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Senocak M, Johansson H, Kanis JA, Turkish Osteoporosis Society (2012) Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int. 23(3):949–55. 10.1007/s00198-011-1655-5 DOI: 10.1007/s00198-011-1655-5
Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11(7):556–561. 10.1007/s001980070075 DOI: 10.1007/s001980070075
Rizkallah M, Bachour F, Khoury ME, Sebaaly A, Finianos B, Hage RE, Maalouf G (2020) Comparison of morbidity and mortality of hip and vertebral fragility fractures: which one has the highest burden? Osteoporos Sarcopenia. 6(3):146–150. 10.1016/j.afos.2020.07.002 DOI: 10.1016/j.afos.2020.07.002
Gurger M (2019) Factors impacting 1-year mortality after hip fractures in elderly patients: a retrospective clinical study. Niger J Clin Pract 22(5):648–651. 10.4103/njcp.njcp_327_18 DOI: 10.4103/njcp.njcp_327_18
Türkiye Endokrinoloji ve Metabolizma Derneği Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu. Bayt Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Sti. Baskı Tarihi: Kasım 2020. ISBN: 987-605-4011-41-4
Beaudart C, Biver E, Bruyère O, Cooper C, Al-Daghri N, Reginster JY, Rizzoli R (2018) Quality of life assessment in musculo-skeletal health. Aging Clin Exp Res 30(5):413–418. 10.1007/s40520-017-0794-8 DOI: 10.1007/s40520-017-0794-8
Kirazlı Y, Atamaz Çalış F, El Ö, Kutsal YG, Peker Ö, Sindel D, Tuzun Ş, Gogas Yavuz D, Durmaz B, Akarirmak Ü, Bodur H, Hamuryudan V, Inceboz U, Öncel S (2020) Updated approach for the management of osteoporosis in Turkey: a consensus report. Arch Osteoporos 15(1):137. 10.1007/s11657-020-00799-0 DOI: 10.1007/s11657-020-00799-0
Aziziyeh R, Amin M, Habib M, Garcia Perlaza J, Szafranski K, McTavish RK, Disher T, Lüdke A, Cameron C (2019) The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. J Med Econ 22(7):638–644. 10.1080/13696998.2019.1590843 DOI: 10.1080/13696998.2019.1590843
Berry SD, Kiel DP, Colón-Emeric C (2019) Hip fractures in older adults in 2019. JAMA 321(22):2233–2234 DOI: 10.1001/jama.2019.5453
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C, IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–56. 10.1007/s00198-012-1964-3 DOI: 10.1007/s00198-012-1964-3
Kutsal YG, Atalay A, Arslan S, Başaran A, Cantürk F, Cindaş A, Eryavuz M, Irdesel J, Karadavut KI, Kirazli Y, Sindel D, Senel K, Güler-Uysal F, Yildirim K (2005) Awareness of osteoporotic patients. Osteoporos Int 16(2):128–133. 10.1007/s00198-004-1678-2 DOI: 10.1007/s00198-004-1678-2
Keskin Y, Cekin MD, Gunduz H, Luleci NE, Giray E, Sur H, Akyuz G (2014) The prevalence of osteoporosis in the Thrace region of Turkey: a community-based study. Turk J Phys Med Rehab 60(4):335–340 DOI: 10.5152/tftrd.2014.34033
Kucukler FK, Simsek Y, Turk AÇ, Arduc A, Guler S (2017) Osteoporosis and silent vertebral fractures in nursing home resident elderly men in Turkey. J Clin Densitom 20(2):188–195. 10.1016/j.jocd.2015.05.064 DOI: 10.1016/j.jocd.2015.05.064
Kilci O, Un C, Sacan O, Gamli M, Baskan S, Baydar M, Ozkurt B (2016) Postoperative mortality after hip fracture surgery: a 3 years follow up. PLoS ONE 11(10):e0162097. 10.1371/journal.pone.0162097 DOI: 10.1371/journal.pone.0162097
Tanriover MD, Oz SG, Tanriover A, Kilicarslan A, Turkmen E, Guven GS, Saracbasi O, Tokgozoglu M, Sozen T (2010) Hip fractures in a developing country: osteoporosis frequency, predisposing factors and treatment costs. Arch Gerontol Geriatr 50(3):e13-8. 10.1016/j.archger.2009.04.010 DOI: 10.1016/j.archger.2009.04.010
Cobden A, Cobden SB, Camurcu Y, Ucpunar H, Duman S, Sofu H (2019) Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture. Arch Osteoporos 14(1):100. 10.1007/s11657-019-0657-3 DOI: 10.1007/s11657-019-0657-3
Aziziyeh R, Garcia Perlaza J, Saleem N, Kirazlı Y, Akalın E, McTavish RK, Duperrouzel C, Cameron C (2020) The burden of osteoporosis in Turkey: a scorecard and economic model. Arch Osteoporos 15(1):128. 10.1007/s11657-020-00801-9 DOI: 10.1007/s11657-020-00801-9
Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, Yuen CK, Lewiecki EM (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221.e1–10. 10.1016/j.amjmed.2015.09.020 DOI: 10.1016/j.amjmed.2015.09.020
Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22(4):453–471. 10.1016/j.jocd.2019.07.001 DOI: 10.1016/j.jocd.2019.07.001
Karahan AY, Kaya B, Kuran B, Altındag O, Yildirim P, Dogan SC, Basaran A, Salbas E, Altınbilek T, Guler T, Tolu S, Hasbek Z, Ordahan B, Kaydok E, Yucel U, Yesilyurt S, Polat AD, Cubukcu M, Nas O, Sarp U, Yasar O, Kucuksarac S, Turkoglu G, Karadag A, Bagcaci S, Erol K, Guler E, Tuna S, Yildirim A, Karpuz S (2016) Common mistakes in the dual-energy X-ray absorptiometry (DXA) in Turkey. A retrospective descriptive multicenter study. Acta Medica (Hradec Kralove) 59(4):117–123. 10.14712/18059694.2017.38 DOI: 10.14712/18059694.2017.38
Tuna F, Yavuz S, Demirbağ Kabayel DD, Sarıkaya A (2017) Effects of clinical reanalysis in dual energy X-ray absorptiometry reports. Turk J Phys Med Rehabil 63(3):201–206. 10.5606/tftrd.2017.595 DOI: 10.5606/tftrd.2017.595
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–81. 10.1007/s00198-014-2794-2 DOI: 10.1007/s00198-014-2794-2
Lenchik L, Rogers LF, Delmas PD, Genant HK (2004) Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. AJR Am J Roentgenol 183(4):949–958. 10.2214/ajr.183.4.1830949 DOI: 10.2214/ajr.183.4.1830949
Yang J, Cosman F, Stone PW, Li M, Nieves JW (2020) Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective? Osteoporos Int 31(12):2321–2335. 10.1007/s00198-020-05588-6 DOI: 10.1007/s00198-020-05588-6
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A, National Osteoporosis Guideline Group (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408. https://doi.org/10.1007/s00198-008-0712-1. Erratum in: Osteoporos Int. 2009;20(3):499–502
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, McCloskey EV (2020) Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures. Osteoporos Int 31(10):1817–1828. 10.1007/s00198-020-05517-7 DOI: 10.1007/s00198-020-05517-7
Alpdemir M, Alpdemir MF (2019) Vitamin D deficiency status in Turkey: a meta-analysis. Int J Med Biochem 2(3):118–131. 10.14744/ijmb.2019.04127 DOI: 10.14744/ijmb.2019.04127
Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165. 10.1007/s11154-017-9424-1 DOI: 10.1007/s11154-017-9424-1
Russo CR (2009) The effects of exercise on bone. Basic concepts and implications for the prevention of fractures. Clin Cases Miner Bone Metab 6(3):223–8
Wallace JI (2017) Malnutrition and enteral/parenteral alimentation, Hazzard’s Geriatric Medicine and Gerontology. Chapter 35, 7th edn. The McGraw-Hill Companies, New York, p 737
Bahat G, Tufan F, Bahat Z, Aydin Y, Tufan A, Akpinar TS, Erten N, Karan MA (2013) Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male 16(2):67–72. 10.3109/13685538.2013.771329 DOI: 10.3109/13685538.2013.771329
Bahat G, Tufan A, Aydin Y, Tufan F, Bahat Z, Akpinar TS, Soyluk O, Erten N, Karan MA (2015) The relationship of body mass index and the functional status of community-dwelling female older people admitting to a geriatric outpatient clinic. Aging Clin Exp Res 27(3):303–308. 10.1007/s40520-014-0291-2 DOI: 10.1007/s40520-014-0291-2
Saka B, Ozkaya H, Karisik E, Akin S, Akpinar TS, Tufan F, Bahat G, Dogan H, Horasan Z, Cesur K, Erten N, Karan MA (2016) Malnutrition and sarcopenia are associated with increased mortality rate in nursing home residents: a prospective study. European Geriatric Medicine 7(3):232–238 DOI: 10.1016/j.eurger.2015.12.010
Bahat G, Kilic C, Altinkaynak M, Akif KM (2020) Comparison of standard versus population-specific handgrip strength cut-off points in the detection of probable sarcopenia after launch of EWGSOP2. Aging Male 23(5):1564–1569. 10.1080/13685538.2020.1870038 DOI: 10.1080/13685538.2020.1870038
Bahat G, Kilic C, Ozkok S, Ozturk S, Karan MA (2021) Associations of sarcopenic obesity versus sarcopenia alone with functionality. Clin Nutr 40(5):2851–2859. 10.1016/j.clnu.2021.04.002 DOI: 10.1016/j.clnu.2021.04.002
Halil M, Ulger Z, Varlı M, Döventaş A, Oztürk GB, Kuyumcu ME, Yavuz BB, Yesil Y, Tufan F, Cankurtaran M, Saka B, Sahin S, Curgunlu A, Tekin N, Akçiçek F, Karan MA, Atlı T, Beger T, Erdinçler DS, Arıoğul S (2014) Sarcopenia assessment project in the nursing homes in Turkey. Eur J Clin Nutr 68(6):690–694. 10.1038/ejcn.2014.15 DOI: 10.1038/ejcn.2014.15
Yilmaz O, Bahat G, Kucukdagli, Ozalp H, Cakmakci C, Karan MA (2018) Poliklinikte ayaktan başvuran yaşlıların beslenme içeriği yeterli mi? 11. Akademik Geriatri Kongresi. 19–23 Nisan. Syf 131–132
Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber CC, Sobotka L, van Asselt D, Wirth R, Bischoff SC (2019) ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 38(1):10–47. 10.1016/j.clnu.2018.05.024 DOI: 10.1016/j.clnu.2018.05.024
Shah M (2017) Role of nutrition inmusculoskeletal health. In: Nonpharmacological management of osteoporosis. Springer, pp 53–59. https://doi.org/10.1007/978-3-319-54016-0_5
Matsumoto H, Tanimura C, Kushida D, Osaka H, Kawabata Y, Hagino H (2020) FRAX score and recent fall history predict the incidence for sarcopenia in community-dwelling older adults: a prospective cohort study. Osteoporos Int 31(10):1985–1994. 10.1007/s00198-020-05447-4 DOI: 10.1007/s00198-020-05447-4
Harvey NC, Odén A, Orwoll E, Lapidus J, Kwok T, Karlsson MK et al (2018) Falls predict fractures independently of FRAX probability: a Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res. 33(3):510–516. 10.1002/jbmr.3331 DOI: 10.1002/jbmr.3331
Bahat Öztürk G, Kılıç C, Bozkurt ME, Karan MA (2021) Prevalence and associates of fear of falling among community-dwelling older adults. J Nutr Health Aging 25(4):433–439. 10.1007/s12603-020-1535-9 DOI: 10.1007/s12603-020-1535-9
Phelan EA, Mahoney JE, Voit JC, Stevens JA (2015) Assessment and management of fall risk in primary care settings. Med Clin North Am 99(2):281–293. 10.1016/j.mcna.2014.11.004 DOI: 10.1016/j.mcna.2014.11.004
Cuevas-Trisan R (2019) Balance problems and fall risks in older adults. Clin Geriatr Med 35(2):173–183. 10.1016/j.cger.2019.01.008 DOI: 10.1016/j.cger.2019.01.008
Thomas E, Battaglia G, Patti A, Brusa J, Leonardi V, Palma A et al (2019) Physical activity programs for balance and fall prevention in elderly: a systematic review. Medicine (Baltimore) 98(27):e16218. 10.1097/MD.0000000000016218 DOI: 10.1097/MD.0000000000016218
Erhan B, Ataker Y (2020) Rehabilitation of patients with osteoporotic fractures. J Clin Densitom 23(4):534–538. 10.1016/j.jocd.2020.06.006 DOI: 10.1016/j.jocd.2020.06.006
Carter ND, Khan KM, McKay HA, Petit MA, Waterman C, Heinonen A, Janssen PA, Donaldson MG, Mallinson A, Riddell L, Kruse K, Prior JC, Flicker L (2002) Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167(9):997–1004. Erratum in: CMAJ. 2003;168(2):152
Çergel Y, Topuz O, Alkan H, Sarsan A, Sabir AN (2019) The effects of short-term back extensor strength training in postmenopausal osteoporotic women with vertebral fractures: comparison of supervised and home exercise program. Arch Osteoporos 14(1):82. 10.1007/s11657-019-0632-z DOI: 10.1007/s11657-019-0632-z
Murata K, Watanabe G, Kawaguchi S, Kanaya K, Horigome K, Yajima H, Morita T, Yamashita T (2012) Union rates and prognostic variables of osteoporotic vertebral fractures treated with a rigid external support. J Neurosurg Spine 17(5):469–475. 10.3171/2012.7.SPINE122 DOI: 10.3171/2012.7.SPINE122
Valentin GH, Pedersen LN, Maribo T (2014) Wearing an active spinal orthosis improves back extensor strength in women with osteoporotic vertebral fractures. Prosthet Orthot Int 38(3):232–238. 10.1177/0309364613497393 DOI: 10.1177/0309364613497393
Kutsal YG (2014) Yaşlıda osteoporoz. Kutsal YG, İrdesel J, Borman P, Ordu Gökkaya K (eds). Geriatrik Romatoloji. Öncü kitabevi s:351–366
Bahat G, Ilhan B, Erdogan T, Halil M, Savas S, Ulger Z, Akyuz F, Bilge AK, Cakir S, Demirkan K, Erelel M, Guler K, Hanagasi H, Izgi B, Kadioglu A, Karan A, Kulaksizoglu IB, Mert A, Ozturk S, Satman I, Sever MS, Tukek T, Uresin Y, Yalcin O, Yesilot N, Oren MM, Karan MA (2020) Turkish inappropriate medication use in older adults (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur Geriatr Med 11(3):491–498. 10.1007/s41999-020-00297-z DOI: 10.1007/s41999-020-00297-z
Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A, Hiligsmann M, European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645–1669. 10.1007/s00198-020-05378-0 DOI: 10.1007/s00198-020-05378-0
Itkonen ST, Erkkola M, Lamberg-Allardt CJE (2018) Vitamin D fortification of fluid milk products and their contribution to vitamin D intake and vitamin D status in observational studies-a review. Nutrients 10(8):1054. 10.3390/nu10081054 DOI: 10.3390/nu10081054
Atar MÖ (2018) Yaşlılarda osteoporoz ve osteomalazi. Sonel Tur B (ed). Yaşlılar için fiziksel Rehabilitasyon. Yaşlılığa çok yönlü bakış. Hedef Kitabevi. Ankara, s:84–93
Vandenbroucke A, Luyten FP, Flamaing J, Gielen E (2017) Pharmacological treatment of osteoporosis in the oldest old. Clin Interv Aging 6(12):1065–1077. 10.2147/CIA.S131023 DOI: 10.2147/CIA.S131023
Institute of Medicine. Report at a glance. Report brief: dietary reference intakes for calcium and vitamin D, released 11/30/2010. http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-forCalcium-and-Vitamin-D/Report-Brief.aspx. Accessed on Dec 01, 2010
Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A (2016) Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 176(2):175–183. 10.1001/jamainternmed.2015.7148 DOI: 10.1001/jamainternmed.2015.7148
Rizzoli R (2021) Vitamin D supplementation: upper limit for safety revisited? Aging Clin Exp Res. 33(1):19–24. 10.1007/s40520-020-01678-x DOI: 10.1007/s40520-020-01678-x
Fuggle NR, Cooper C, Harvey NC, Al-Daghri N, Brandi ML, Bruyere O, Cano A, Dennison EM, Diez-Perez A, Kaufman JM, Palacios S, Prieto-Alhambra D, Rozenberg S, Thomas T, Tremollieres F, Rizzoli R, Kanis JA, Reginster JY (2020) Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs 80(15):1537–1552. 10.1007/s40265-020-01364-2.PMID:32725307;PMCID:PMC7536167 DOI: 10.1007/s40265-020-01364-2.PMID:32725307;PMCID:PMC7536167
Curtis EM, Cooper C, Harvey NC (2021) Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say? Aging Clin Exp Res 33(3):479–494. 10.1007/s40520-021-01799-x DOI: 10.1007/s40520-021-01799-x
Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology (Oxford). 52(6):968–85. 10.1093/rheumatology/ket007 DOI: 10.1093/rheumatology/ket007
Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44. https://doi.org/10.1007/s00198-018-4704-5. Erratum in: Osteoporos Int. 2020;31(1):209. Erratum in: Osteoporos Int. 2020;31(4):801
Meier C, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, Ferrari S (2017) Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss Med Wkly 147:w14484. 10.4414/smw.2017.14484 DOI: 10.4414/smw.2017.14484
Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. 10.4158/GL-2020-0524SUPPL DOI: 10.4158/GL-2020-0524SUPPL
Diab DL, Watts NB (2013) Bisphosphonate drug holiday: who, when and how long. Ther Adv Musculoskelet Dis 5(3):107–111. 10.1177/1759720X13477714 DOI: 10.1177/1759720X13477714
Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350(12):1189–99. 10.1056/NEJMoa030897 DOI: 10.1056/NEJMoa030897
Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, Nelson VA, Ullman K, Butler M, Olson CM, Taylor BC, Brasure M, Wilt TJ (2019) Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann Intern Med 171(1):37–50. 10.7326/M19-0533 DOI: 10.7326/M19-0533
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31(1):1–12. 10.1007/s00198-019-05176-3. Erratum in: Osteoporos Int. 2020;31(4):797–798
Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513–523. 10.1016/S2213-8587(17)30138-9 DOI: 10.1016/S2213-8587(17)30138-9
Li N, Cornelissen D, Silverman S, Pinto D, Si L, Kremer I, Bours S, de Bot R, Boonen A, Evers S, van den Bergh J, Reginster JY, Hiligsmann M (2021) An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis. Pharmacoeconomics. 39(2):181–209. 10.1007/s40273-020-00965-9 DOI: 10.1007/s40273-020-00965-9
Lems WF, Raterman HG (2017) Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs. Ther Adv Musculoskelet Dis 9(12):299–316. 10.1177/1759720X17732562 DOI: 10.1177/1759720X17732562
Guggina P, Flahive J, Hooven FH, Watts NB, Siris ES, Silverman S, Roux C, Pfeilschifter J, Greenspan SL, Díez-Pérez A, Cooper C, Compston JE, Chapurlat R, Boonen S, Adachi JD, Anderson FA Jr, Gehlbach S, GLOW Investigators (2012) Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone 51(6):975–80. 10.1016/j.bone.2012.08.130 DOI: 10.1016/j.bone.2012.08.130
Klop C, Gibson-Smith D, Elders PJ et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010. Osteoporos Int 26(7):1919–1928. 10.1007/s00198-015-3098-x DOI: 10.1007/s00198-015-3098-x
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031. Erratum in: J Oral Maxillofac Surg. 2015;73(7):1440. Erratum in: J Oral Maxillofac Surg. 2015;73(9):1879
Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 11(8):14. 10.1038/s41413-020-0088-1 DOI: 10.1038/s41413-020-0088-1
Rosen HN (2021) Risks of bisphosphonate therapy in patients with osteoporosis. UpToDate. Access date: Sepember, 22, 2021
https://www.sheffield.ac.uk/NOGG%20Guideline%202017.pdf. Access date September 22, 2021
Kossioni AE (2018) The association of poor oral health parameters with malnutrition in older adults: a review considering the potential implications for cognitive impairment. Nutrients 10(11):1709. 10.3390/nu10111709 DOI: 10.3390/nu10111709
Yoshida M, Suzuki R, Kikutani T (2013) Nutrition and oral status in elderly people. Jpn Dent Sci Rev 50:9–14. 10.1016/j.jdsr.2013.09.001 DOI: 10.1016/j.jdsr.2013.09.001
https://www.aegisdentalnetwork.com/cced/2020/05/teeth-in-geriatric-patients-to-restore-or-extract. Access date September 23, 2021
Symonds C, Kline G (2018) Warning of an increased risk of vertebral fracture after stopping denosumab. CMAJ 190(16):E485–E486. 10.1503/cmaj.180115 DOI: 10.1503/cmaj.180115.PMID:29685907;PMCID:PMC5915244
Denosumab: drug information Lexicomp, UpToDate. 2021. Access date: March 2021
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622. 10.1210/jc.2019-00221 DOI: 10.1210/jc.2019-00221
Liberman D, Cheung A (2015) A practical approach to osteoporosis management in the geriatric population. Can Geriatr J 18(1):29–34. 10.5770/cgj.18.129 DOI: 10.5770/cgj.18.129
Sleeman A, Clements JN (2019) Abaloparatide: a new pharmacological option for osteoporosis. Am J Health Syst Pharm 76(3):130–135. 10.1093/ajhp/zxy022 DOI: 10.1093/ajhp/zxy022
Reginster J, Bianic F, Campbell R, Martin M, Williams SA, Fitzpatrick LA (2019) Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis. Osteoporos Int 30(7):1465–1473. 10.1007/s00198-019-04947-2 DOI: 10.1007/s00198-019-04947-2
Paik J, Scott LJ (2020) Romosozumab: a review in postmenopausal osteoporosis. Drugs Aging 37(11):845-855. https://doi.org/10.1007/s40266-020-00793-8. Erratum in: Drugs Aging. 2020
Rauner M, Taipaleenmäki H, Tsourdi E, Winter EM (2021) Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application. J Clin Med 10(4):787. 10.3390/jcm10040787 DOI: 10.3390/jcm10040787
Wu CH, Kao IJ, Hung WC, Lin SC, Liu HC, Hsieh MH, Bagga S, Achra M, Cheng TT, Yang RS (2018) Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature. Osteoporos Int 29(6):1227–1242. 10.1007/s00198-018-4411-2 DOI: 10.1007/s00198-018-4411-2
Fuggle NR, Kassim Javaid M, Fujita M, Halbout P, Dawson-Hughes B, Rizzoli R, Reginster JY, Kanis JA, Cooper C (2020) Fracture risk assessment and How to implement a fracture liaison service. In: Falaschi P, Marsh D, editors. Orthogeriatrics: the management of older patients with fragility fractures [Internet]. Springer, Cham; 2021. Chapter 14
https://www.capturethefracture.org/index.php/map-of-best-practice. Access date September 22, 2021
Yu M, Downey C, Torralba KD (2020) The fracture liaison service to close the osteoporosis care gap: a leadership educational model for undergraduate and postgraduate trainees. Clin Rheumatol 39:619–626. 10.1007/s10067-019-04796-8 DOI: 10.1007/s10067-019-04796-8
Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging 12:117–127. Published 2017. https://doi.org/10.2147/CIA.S85551
Bahat G, Catikkas NM, Karan MA, Reginster JY (2021) Orthogeriatrics: a vital requirement for improving fragility fracture patient care internationally with particular reference to Turkey. Arch Osteoporos 16(1):103. 10.1007/s11657-021-00967-w DOI: 10.1007/s11657-021-00967-w
Soulis G, Kotovskaya Y, Bahat G, Duque S, Gouiaa R, Ekdahl AW, Sieber C, Petrovic M, Benetos A (2021) Geriatric care in European countries where geriatric medicine is still emerging. Eur Geriatr Med. 12(1):205–211. 10.1007/s41999-020-00419-7 DOI: 10.1007/s41999-020-00419-7
